Update on CARDIO-TTRansform Phase 3 trial of eplontersen in adults with transthyretin-mediated amyloid cardiomyopathy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. PSKY
5. TSLA
6. AMD
7. USO
8. AMC
9. META
10. NUAI

Go back to Update on CARDIO-TTRansform Phase 3 trial of eplontersen in adults with transthyretin-mediated amyloid cardiomyopathy
(NASDAQ: IONS) Delayed: 44.82 +0.38 (0.86%)
Previous Close $44.44    52 Week High $62.68 
Open $44.95    52 Week Low $19.59 
Day High $45.25    P/E N/A 
Day Low $44.20    EPS $0.00 
Volume 2,849,790